Results 281 to 290 of about 353,556 (317)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

The Role of Bronchoalveolar Lavage in Therapeutic Antimicrobial Choices for Hematologic Patients with Pulmonary Infiltrates. [PDF]

open access: yesMedicina (Kaunas)
Patrucco F   +10 more
europepmc   +1 more source

NORSE secondary to anti‐GAD65 antibody‐positive encephalitis treated with novel adjunctive rapid titration VNS protocol

open access: yesEpilepsia Open, EarlyView.
Abstract New Onset Refractory Status Epilepticus (NORSE) is a rare and severe condition characterized by refractory seizures in individuals without a prior history of epilepsy. This case report describes a 37‐year‐old woman diagnosed with anti‐glutamic acid decarboxylase 65 (anti‐GAD65) antibody‐positive encephalitis‐related NORSE.
Mingyu Li   +9 more
wiley   +1 more source

The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia. [PDF]

open access: yesRespir Res
Huang L   +12 more
europepmc   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Is a Benign Disease Course Possible in Untreated AQP4-IgG NMOSD? [PDF]

open access: yesEur J Neurol
Siriratnam P   +5 more
europepmc   +1 more source

Harnessing Biomarker Activatable Probes for Early Stratification and Timely Assessment of Therapeutic Efficacy in Cancer

open access: yesExploration, EarlyView.
Considering the rapid progression of cancer in most cases, any delay in evaluating therapy outcomes poses a significant threat to patients’ lives. Consequently, it is imperative to implement stratification and conduct timely evaluations of therapeutic effects either before or during the early stages of cancer treatment.
Qinrui Fu
wiley   +1 more source

Home - About - Disclaimer - Privacy